Nontraditional Epilepsy Treatment Approaches

Neurotherapeutics

Volumn 6, Issue 2, 2009, Pages 213-217

  Rogawski, Michael A ^a   Holmes, Gregory L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE; GESTAGEN; NEUROSTEROID;

BRAIN DEPTH STIMULATION; CATAMENIAL EPILEPSY; CELL THERAPY; COOLING; DRUG DELIVERY SYSTEM; EDITORIAL; EPILEPSY; GENE THERAPY; HORMONAL THERAPY; HUMAN; KETOGENIC DIET; MEDICAL RESEARCH; MEDICAL SOCIETY; PRIORITY JOURNAL; THERMODYNAMICS; VAGUS NERVE STIMULATION;

EID: 62949124317     PISSN: 19337213     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurt.2009.02.002     Document Type: Editorial

References (9)

1. Pearce J.M. Bromide, the first effective antiepileptic agent. J Neurol Neurosurg Psychiatry 72 (2002) 412
2. Brodie M.J., and Kwan P. Staged approach to epilepsy management. Neurology 58 8 Suppl 5 (2002) S2-S8
3. Loring D.W., Marino S., and Meador K.J. Neuropsychological and behavioral effects of antiepilepsy drugs. Neuropsychol Rev 17 (2007) 413-425
4. Löscher W., and Schmidt D. New horizons in the development of antiepileptic drugs. Epilepsy Res 50 (2002) 3-16
5. Löscher W., and Schmidt D. New horizons in the development of antiepileptic drugs: the search for new targets. Epilepsy Res 60 (2004) 77-159
6. Löscher W., and Schmidt D. New Horizons in the development of antiepileptic drugs: innovative strategies. Epilepsy Res 69 (2006) 183-272
7. Dichter M.A. Innovative clinical trial designs for future antiepileptic drugs. Epilepsia 48 Suppl 1 (2007) 26-30
8. Rosenow J., Das K., Rovit R.L., and Couldwell W.T. Irving S. Cooper and his role in intracranial stimulation for movement disorders and epilepsy. Stereotact Funct Neurosurg 78 (2002) 95-112
9. Löscher W., Gernert M., and Heinemann U. Cell and gene therapies in epilepsy-promising avenues or blind alleys?. Trends Neurosci 31 (2008) 62-73